ALX Oncology Holdings Inc. (ALXO)
NASDAQ: ALXO · Real-Time Price · USD
1.990
+0.030 (1.53%)
May 20, 2026, 9:43 AM EDT - Market open
ALX Oncology Holdings Market Cap
ALX Oncology Holdings has a market cap or net worth of $267.77 million as of May 20, 2026. Its market cap has increased by 811.80% in one year.
Market Cap
267.77M
Enterprise Value
131.93M
1-Year Change
811.80%
Ranking
Category
Stock Price
$1.99
Market Cap Chart
Since July 17, 2020, ALX Oncology Holdings's market cap has decreased from $1.06B to $267.77M, a decrease of -74.65%. That is a compound annual growth rate of -20.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 19, 2026 | 263.74M | 330.48% |
| Dec 31, 2025 | 61.27M | -30.44% |
| Dec 31, 2024 | 88.08M | -88.13% |
| Dec 29, 2023 | 741.80M | 61.50% |
| Dec 30, 2022 | 459.31M | -47.23% |
| Dec 31, 2021 | 870.34M | -74.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AC Immune | 279.75M |
| Eledon Pharmaceuticals | 276.74M |
| Nuvectis Pharma | 273.21M |
| Silence Therapeutics | 272.54M |
| Cellectis | 272.52M |
| Inhibikase Therapeutics | 267.56M |
| Compugen | 258.13M |
| Zentalis Pharmaceuticals | 252.00M |